29Jul
National Retailer Pulls CBD Products From Shelves in Response to FDA Warning to Product Manufacturer
On Monday, July 22, the U.S. Food and Drug Administration (FDA) took a rare and significant step in issuing a warning letter to Curaleaf Holdings, Inc. (Curaleaf), one of the country’s larger producers of CBD-based products, regarding Curaleaf’s...
By:
Manatt, Phelps & Phillips, LLP
Related
On September 18, 2019, California Governor Gavin Newsom signed into law the controversial Assembly B...
Read More >
16,000 nationwide complaints to OSHA agencies since April prompt sector-specific guidance - OSHA co...
Read More >
On November 22nd, the CFPB issued a press release announcing that a stipulated final judgment and or...
Read More >
On April 8, 2020, Governor Murphy signed Executive Order No. 122 (the Order) strengthening mitigatio...
Read More >
Because stockholder activism strikes at the heart of a company’s governance structure – often thre...
Read More >
This episode offers the top 10 new employment laws coming out of New York in the first half of 2019....
Read More >